Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Clin Genet ; 106(3): 224-233, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38553872

ABSTRACT

Exome sequencing (ES) has identified biallelic kinesin family member 12 (KIF12) mutations as underlying neonatal cholestatic liver disease. We collected information on onset and progression of this entity. Among consecutively referred pediatric patients at our centers, diagnostic ES identified 4 patients with novel, biallelic KIF12 variants using the human GRCh38 reference sequence, as KIF12 remains incompletely annotated in the older reference sequence GRCh37. A review of these and of 21 reported patients with KIF12 variants found that presentation with elevated serum transaminase activity in the context of trivial respiratory infection, without clinical features of liver disease, was more common (n = 18) than manifest cholestatic disease progressing rapidly to liver transplantation (LT; n = 7). Onset of liver disease was at age <1 year in 15 patients; LT was more common in this group. Serum gamma-glutamyl transpeptidase activity (GGT) was elevated in all patients, and total bilirubin was elevated in 15 patients. Liver fibrosis or cirrhosis was present in 14 of 18 patients who were biopsied. The 16 different pathogenic variants and 11 different KIF12 genotypes found were not correlated with age of onset or progression to LT. Identification of biallelic pathogenic KIF12 variants distinguishes KIF12-related disease from other entities with elevated GGT.


Subject(s)
Kinesins , Liver Diseases , Mutation , gamma-Glutamyltransferase , Humans , Kinesins/genetics , gamma-Glutamyltransferase/blood , gamma-Glutamyltransferase/genetics , Male , Female , Liver Diseases/genetics , Liver Diseases/pathology , Infant , Exome Sequencing , Infant, Newborn , Genetic Predisposition to Disease , Liver Transplantation , Genotype , Alleles , Child, Preschool , Child
2.
Am J Hum Genet ; 104(4): 758-766, 2019 04 04.
Article in English | MEDLINE | ID: mdl-30929739

ABSTRACT

By using exome sequencing and a gene matching approach, we identified de novo and inherited pathogenic variants in KDM3B in 14 unrelated individuals and three affected parents with varying degrees of intellectual disability (ID) or developmental delay (DD) and short stature. The individuals share additional phenotypic features that include feeding difficulties in infancy, joint hypermobility, and characteristic facial features such as a wide mouth, a pointed chin, long ears, and a low columella. Notably, two individuals developed cancer, acute myeloid leukemia and Hodgkin lymphoma, in childhood. KDM3B encodes for a histone demethylase and is involved in H3K9 demethylation, a crucial part of chromatin modification required for transcriptional regulation. We identified missense and truncating variants, suggesting that KDM3B haploinsufficiency is the underlying mechanism for this syndrome. By using a hybrid facial-recognition model, we show that individuals with a pathogenic variant in KDM3B have a facial gestalt, and that they show significant facial similarity compared to control individuals with ID. In conclusion, pathogenic variants in KDM3B cause a syndrome characterized by ID, short stature, and facial dysmorphism.


Subject(s)
Craniofacial Abnormalities/genetics , Developmental Disabilities/genetics , Dwarfism/genetics , Genetic Variation , Intellectual Disability/genetics , Jumonji Domain-Containing Histone Demethylases/genetics , Musculoskeletal Abnormalities/genetics , Body Height , Child , Exome , Face , Female , Genetic Association Studies , Germ-Line Mutation , Haploinsufficiency , Histones/chemistry , Humans , Male , Mutation, Missense , Phenotype
3.
Hum Mol Genet ; 28(5): 828-841, 2019 03 01.
Article in English | MEDLINE | ID: mdl-30445423

ABSTRACT

The syndromic form of congenital sodium diarrhea (SCSD) is caused by bi-allelic mutations in SPINT2, which encodes a Kunitz-type serine protease inhibitor (HAI-2). We report three novel SCSD patients, two novel SPINT2 mutations and review published cases. The most common findings in SCSD patients were choanal atresia (20/34) and keratitis of infantile onset (26/34). Characteristic epithelial tufts on intestinal histology were reported in 13/34 patients. Of 13 different SPINT2 variants identified in SCSD, 4 are missense variants and localize to the second Kunitz domain (KD2) of HAI-2. HAI-2 has been implicated in the regulation of the activities of several serine proteases including prostasin and matriptase, which are both important for epithelial barrier formation. No patient with bi-allelic stop mutations was identified, suggesting that at least one SPINT2 allele encoding a protein with residual HAI-2 function is necessary for survival. We show that the SCSD-associated HAI-2 variants p.Phe161Val, p.Tyr163Cys and p.Gly168Ser all display decreased ability to inhibit prostasin-catalyzed cleavage. However, the SCSD-associated HAI-2 variants inhibited matriptase as efficiently as the wild-type HAI-2. Homology modeling indicated limited solvent exposure of the mutated amino acids, suggesting that they induce misfolding of KD2. This suggests that prostasin needs to engage with an exosite motif located on KD2 in addition to the binding loop (Cys47/Arg48) located on the first Kunitz domain in order to inhibit prostasin. In conclusion our data suggests that SCSD is caused by lack of inhibition of prostasin or a similar protease in the secretory pathway or on the plasma membrane.


Subject(s)
Abnormalities, Multiple/genetics , Abnormalities, Multiple/metabolism , Diarrhea/congenital , Gene Expression Regulation , Membrane Glycoproteins/genetics , Metabolism, Inborn Errors/genetics , Metabolism, Inborn Errors/metabolism , Mutation, Missense , Serine Endopeptidases/metabolism , Adolescent , Amino Acid Sequence , Child , Child, Preschool , Diarrhea/genetics , Diarrhea/metabolism , Disease Susceptibility , Female , Genetic Association Studies , Humans , Infant , Male , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/metabolism , Models, Biological , Models, Molecular , Phenotype , Structure-Activity Relationship
4.
Epilepsia ; 62(11): 2814-2825, 2021 11.
Article in English | MEDLINE | ID: mdl-34453316

ABSTRACT

OBJECTIVE: To investigate the effectiveness and safety of the ketogenic diet (KD) in drug-resistant epilepsy in childhood in relation to the new 2017 International League Against Epilepsy (ILAE) classification of etiology. METHODS: A consecutive cohort of patients treated with the KD were categorized according to the ILAE classification into known (structural, genetic, metabolic, infectious, and immune-mediated) and unknown etiology. Primary outcome was the frequency of patients achieving seizure freedom with the KD at 3 months, secondary outcomes were seizure reduction >50% at 3 months, and both seizure freedom and seizure reduction >50% at 6, 12 months, and at last follow-up (LFU), and adverse effects. Outcomes were compared between etiology groups. RESULTS: Etiology was known in 70% (129/183). Outcomes did not differ at 3 months (known vs unknown: seizure freedom 28% vs 33%, seizure reduction 62 vs 67%), but seizure freedom was significantly less frequent in known etiology at 6 months (26% vs 43%) and beyond (22% vs 37%). Logistic regression identified duration of epilepsy, number of previous antiseizure medications (ASMs), and age-appropriate psychomotor development as positive determinants of outcome. Among individual etiology groups, the effectiveness of KD was relatively best for genetic (33% at LFU) and poorest for metabolic etiology (8% at LFU). The small number of patients with infectious and immune-mediated etiology requires larger numbers in each etiology group to corroborate our results. No differences in type and frequency of adverse effects (in 71%) between etiology groups were observed, requiring medical intervention in 21%. SIGNIFICANCE: The KD was most effective in genetic and unknown etiology, many unknowns probably represent yet unidentified genetic causes. We recommend consequent diagnostic and genetic work-up to identify etiologies that respond best to the KD. The KD should be offered early to infants with genetic epilepsy before deterioration of epileptic symptoms and of psychomotor development.


Subject(s)
Diet, Ketogenic , Drug Resistant Epilepsy , Drug-Related Side Effects and Adverse Reactions , Epilepsy , Cohort Studies , Diet, Ketogenic/adverse effects , Diet, Ketogenic/methods , Drug Resistant Epilepsy/etiology , Epilepsy/diagnosis , Humans , Infant , Retrospective Studies , Seizures , Treatment Outcome
5.
Wien Med Wochenschr ; 171(5-6): 94-101, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33689085

ABSTRACT

Skeletal disorders are inherited disorders with significant skeletal involvement and most of them are rare or extremely rare. Based on the clinical, radiological and genetic phenotype, the group of skeletal disorder comprises more than 450 different and highly heterogeneous disorders. In skeletal disorders rapid and precise diagnoses are urgently needed for patient care and are based on the combination of clinical, radiological and genetic analysis. Novel genetic techniques have revolutionized diagnostics and have a huge impact on counseling of patients and families. Disease-specific long-term management in a multidisciplinary healthcare team in highly specialized centers is recommended to optimize care for these patients. Here we describe a multidisciplinary postnatal approach for the diagnosis and management of patients and families with rare skeletal disorders at the Vienna Bone and Growth Center. We discuss the value of a multidisciplinary diagnostic and management approach in the postnatal setting and provide a diagnostic flowchart for rare skeletal disorders.


Subject(s)
Genetic Testing , Rare Diseases , Humans , Phenotype , Rare Diseases/diagnosis , Rare Diseases/therapy
6.
Hum Mutat ; 41(3): 655-667, 2020 03.
Article in English | MEDLINE | ID: mdl-31705726

ABSTRACT

Congenital disorders of glycosylation (CDGs) comprise a large number of inherited metabolic defects that affect the biosynthesis and attachment of glycans. CDGs manifest as a broad spectrum of disease, most often including neurodevelopmental and skeletal abnormalities and skin laxity. Two patients with biallelic CSGALNACT1 variants and a mild skeletal dysplasia have been described previously. We investigated two unrelated patients presenting with short stature with advanced bone age, facial dysmorphism, and mild language delay, in whom trio-exome sequencing identified novel biallelic CSGALNACT1 variants: compound heterozygosity for c.1294G>T (p.Asp432Tyr) and the deletion of exon 4 that includes the start codon in one patient, and homozygosity for c.791A>G (p.Asn264Ser) in the other patient. CSGALNACT1 encodes CSGalNAcT-1, a key enzyme in the biosynthesis of sulfated glycosaminoglycans chondroitin and dermatan sulfate. Biochemical studies demonstrated significantly reduced CSGalNAcT-1 activity of the novel missense variants, as reported previously for the p.Pro384Arg variant. Altered levels of chondroitin, dermatan, and heparan sulfate moieties were observed in patients' fibroblasts compared to controls. Our data indicate that biallelic loss-of-function mutations in CSGALNACT1 disturb glycosaminoglycan synthesis and cause a mild skeletal dysplasia with advanced bone age, CSGALNACT1-CDG.


Subject(s)
Congenital Disorders of Glycosylation/diagnosis , Congenital Disorders of Glycosylation/genetics , Genetic Association Studies , Genetic Predisposition to Disease , Musculoskeletal Abnormalities/diagnosis , Musculoskeletal Abnormalities/genetics , Mutation , N-Acetylgalactosaminyltransferases/genetics , Amino Acid Sequence , Bone and Bones/abnormalities , Bone and Bones/diagnostic imaging , Facies , Female , High-Throughput Nucleotide Sequencing , Humans , Infant, Newborn , Loss of Function Mutation , Male , Mutation, Missense , Pedigree , Phenotype
7.
Clin Genet ; 98(3): 282-287, 2020 09.
Article in English | MEDLINE | ID: mdl-32557621

ABSTRACT

Biallelic loss-of-function mutations in the centrosomal pericentrin gene (PCNT) cause microcephalic osteodysplastic primordial dwarfism type II (MOPDII), which is characterized by extreme growth retardation, microcephaly, skeletal dysplasia, and dental anomalies. Life expectancy is reduced due to a high risk of cerebral vascular anomalies. Here, we report two siblings with MOPDII and attenuated growth restriction, and pachygyria. Compound heterozygosity for two novel truncated PCNT variants was identified. Both truncated PCNT proteins were expressed in patient's fibroblasts, with a reduced total protein amount compared to control. Patient's fibroblasts showed impaired cell cycle progression. As a novel finding, 20% of patient's fibroblasts were shown to express PCNT comparable to control. This was associated with normal mitotic morphology and normal co-localization of mutated PCNT with centrosome-associated proteins γ-tubulin and centrin 3, suggesting some residual function of truncated PCNT proteins. These data expand the clinical and molecular spectrum of MOPDII and indicate that residual PCNT function might be associated with attenuated growth restriction in MOPDII.


Subject(s)
Antigens/genetics , Dwarfism/genetics , Fetal Growth Retardation/genetics , Genetic Predisposition to Disease , Lissencephaly/genetics , Microcephaly/genetics , Osteochondrodysplasias/genetics , Adolescent , Adult , Alleles , Centrosome/metabolism , Child , Child, Preschool , Dwarfism/pathology , Female , Fetal Growth Retardation/pathology , Fibroblasts/metabolism , Humans , Lissencephaly/pathology , Loss of Function Mutation/genetics , Male , Microcephaly/pathology , Osteochondrodysplasias/pathology , Siblings , Tubulin/genetics , Young Adult
8.
J Pediatr Gastroenterol Nutr ; 68(1): e1-e6, 2019 01.
Article in English | MEDLINE | ID: mdl-30589726

ABSTRACT

Mutations in the nuclear gene DGUOK, encoding deoxyguanosine kinase, cause an infantile hepatocerebral type of mitochondrial depletion syndrome (MDS). We report 6 MDS patients harboring bi-allelic DGUOK mutations, of which 3 are novel, including a large intragenic Austrian founder deletion. One patient was diagnosed with hepatocellular carcinoma aged 6 months, supporting a link between mitochondrial DNA depletion and tumorigenesis; liver transplantation proved beneficial with regard to both tumor treatment and psychomotor development.


Subject(s)
Mitochondrial Diseases/genetics , Austria , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/surgery , DNA, Mitochondrial/genetics , Female , Humans , Infant , Infant, Newborn , Liver/pathology , Liver Neoplasms/genetics , Liver Neoplasms/surgery , Liver Transplantation , Male , Mitochondrial Diseases/pathology , Mitochondrial Diseases/surgery , Mutation
9.
Hum Mutat ; 38(1): 34-38, 2017 01.
Article in English | MEDLINE | ID: mdl-27599773

ABSTRACT

Mutations in genes encoding enzymes responsible for the biosynthesis and structural diversity of glycosaminoglycans (GAGs) cause a variety of disorders affecting bone and connective tissues, including Desbuquois dysplasia (DD). In an infant with prenatal-onset disproportionate short stature, joint laxity, and radiographic findings typical for DD compound-heterozygosity for a large intragenic deletion, and a p.Pro384Arg missense mutation in CSGALNACT1 was found. CSGALNACT1 encodes chondroitin sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1, ChGn-1), which initiates chondroitin sulfate (CS) chain biosynthesis on the so-called GAG-protein linker region tetrasaccharide. Biochemical studies revealed a reduced GalNAc-transferase activity of the Arg-384 mutant protein, whereas no differences in proteoglycan synthesis in fibroblasts and the GAG content in the urine were found between patient and controls. This is the first description of bi-allelic loss-of-function mutations in CSGALNACT1 that produce a skeletal dysplasia reminiscent of the skeletal dysplasia of Csgalnact1-/- mice, and adds to the genetic heterogeneity of DD.


Subject(s)
Joint Instability/diagnosis , Joint Instability/genetics , Musculoskeletal Abnormalities/diagnosis , Musculoskeletal Abnormalities/genetics , N-Acetylgalactosaminyltransferases/deficiency , Child, Preschool , DNA Mutational Analysis , Enzyme Activation , Exons , Female , Gene Expression , Heterozygote , Humans , Infant , Mutation , N-Acetylgalactosaminyltransferases/genetics , N-Acetylgalactosaminyltransferases/metabolism , Phenotype , Radiography , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sequence Deletion , Severity of Illness Index
10.
Hum Mol Genet ; 24(23): 6614-23, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26358773

ABSTRACT

Congenital sodium diarrhea (CSD) refers to an intractable diarrhea of intrauterine onset with high fecal sodium loss. CSD is clinically and genetically heterogeneous. Syndromic CSD is caused by SPINT2 mutations. While we recently described four cases of the non-syndromic form of CSD that were caused by dominant activating mutations in intestinal receptor guanylate cyclase C (GC-C), the genetic cause for the majority of CSD is still unknown. Therefore, we aimed to determine the genetic cause for non-GC-C non-syndromic CSD in 18 patients from 16 unrelated families applying whole-exome sequencing and/or chromosomal microarray analyses and/or direct Sanger sequencing. SLC9A3 missense, splicing and truncation mutations, including an instance of uniparental disomy, and whole-gene deletion were identified in nine patients from eight families with CSD. Two of these nine patients developed inflammatory bowel disease (IBD) at 4 and 16 years of age. SLC9A3 encodes Na(+)/H(+) antiporter 3 (NHE3), which is the major intestinal brush-border Na(+)/H(+) exchanger. All mutations were in the NHE3 N-terminal transport domain, and all missense mutations were in the putative membrane-spanning domains. Identified SLC9A3 missense mutations were functionally characterized in plasma membrane NHE null fibroblasts. SLC9A3 missense mutations compromised NHE3 activity by reducing basal surface expression and/or loss of basal transport function of NHE3 molecules, whereas acute regulation was normal. This study identifies recessive mutations in NHE3, a downstream target of GC-C, as a cause of CSD and implies primary basal NHE3 malfunction as a predisposition for IBD in a subset of patients.


Subject(s)
Abnormalities, Multiple/genetics , Diarrhea/congenital , Metabolism, Inborn Errors/genetics , Mutation , Sodium-Hydrogen Exchangers/genetics , Abnormalities, Multiple/metabolism , Abnormalities, Multiple/physiopathology , Adolescent , Adult , Child , Child, Preschool , DNA Mutational Analysis , Diarrhea/genetics , Diarrhea/metabolism , Diarrhea/physiopathology , Female , Genes, Recessive , Humans , Infant , Infant, Newborn , Inflammatory Bowel Diseases/genetics , Inflammatory Bowel Diseases/metabolism , Inflammatory Bowel Diseases/physiopathology , Intestinal Mucosa/metabolism , Intestines/physiopathology , Male , Metabolism, Inborn Errors/metabolism , Metabolism, Inborn Errors/physiopathology , Microvilli/metabolism , Oligonucleotide Array Sequence Analysis , Sodium-Hydrogen Exchanger 3 , Young Adult
11.
Gut ; 65(8): 1306-13, 2016 08.
Article in English | MEDLINE | ID: mdl-25994218

ABSTRACT

OBJECTIVE: Congenital sodium diarrhoea (CSD) refers to a form of secretory diarrhoea with intrauterine onset and high faecal losses of sodium without congenital malformations. The molecular basis for CSD remains unknown. We clinically characterised a cohort of infants with CSD and set out to identify disease-causing mutations by genome-wide genetic testing. DESIGN: We performed whole-exome sequencing and chromosomal microarray analyses in 4 unrelated patients, followed by confirmatory Sanger sequencing of the likely disease-causing mutations in patients and in their family members, followed by functional studies. RESULTS: We identified novel de novo missense mutations in GUCY2C, the gene encoding receptor guanylate cyclase C (GC-C) in 4 patients with CSD. One patient developed severe, early-onset IBD and chronic arthritis at 4 years of age. GC-C is an intestinal brush border membrane-bound guanylate cyclase, which functions as receptor for guanylin, uroguanylin and Escherichia coli heat-stable enterotoxin. Mutations in GUCY2C were present in different intracellular domains of GC-C, and were activating mutations that enhanced intracellular cyclic guanosine monophosphate accumulation in a ligand-independent and ligand-stimulated manner, following heterologous expression in HEK293T cells. CONCLUSIONS: Dominant gain-of-function GUCY2C mutations lead to elevated intracellular cyclic guanosine monophosphate levels and could explain the chronic diarrhoea as a result of decreased intestinal sodium and water absorption and increased chloride secretion. Thus, mutations in GUCY2C indicate a role for this receptor in the pathogenesis of sporadic CSD.


Subject(s)
Abnormalities, Multiple , Diarrhea/congenital , Intestinal Mucosa , Intestines , Metabolism, Inborn Errors , Receptors, Guanylate Cyclase-Coupled/genetics , Receptors, Peptide/genetics , Abnormalities, Multiple/genetics , Abnormalities, Multiple/physiopathology , Diarrhea/genetics , Diarrhea/physiopathology , Female , Genetic Predisposition to Disease , Guanosine Monophosphate/metabolism , Humans , Infant , Intestinal Absorption , Intestinal Mucosa/metabolism , Intestines/physiopathology , Male , Metabolism, Inborn Errors/genetics , Metabolism, Inborn Errors/physiopathology , Mutation, Missense , Receptors, Enterotoxin , Sodium/metabolism
12.
Am J Hum Genet ; 93(5): 932-44, 2013 Nov 07.
Article in English | MEDLINE | ID: mdl-24183451

ABSTRACT

Bidirectional (anterograde and retrograde) motor-based intraflagellar transport (IFT) governs cargo transport and delivery processes that are essential for primary cilia growth and maintenance and for hedgehog signaling functions. The IFT dynein-2 motor complex that regulates ciliary retrograde protein transport contains a heavy chain dynein ATPase/motor subunit, DYNC2H1, along with other less well functionally defined subunits. Deficiency of IFT proteins, including DYNC2H1, underlies a spectrum of skeletal ciliopathies. Here, by using exome sequencing and a targeted next-generation sequencing panel, we identified a total of 11 mutations in WDR34 in 9 families with the clinical diagnosis of Jeune syndrome (asphyxiating thoracic dystrophy). WDR34 encodes a WD40 repeat-containing protein orthologous to Chlamydomonas FAP133, a dynein intermediate chain associated with the retrograde intraflagellar transport motor. Three-dimensional protein modeling suggests that the identified mutations all affect residues critical for WDR34 protein-protein interactions. We find that WDR34 concentrates around the centrioles and basal bodies in mammalian cells, also showing axonemal staining. WDR34 coimmunoprecipitates with the dynein-1 light chain DYNLL1 in vitro, and mining of proteomics data suggests that WDR34 could represent a previously unrecognized link between the cytoplasmic dynein-1 and IFT dynein-2 motors. Together, these data show that WDR34 is critical for ciliary functions essential to normal development and survival, most probably as a previously unrecognized component of the mammalian dynein-IFT machinery.


Subject(s)
Carrier Proteins/genetics , Cytoplasmic Dyneins/genetics , Ellis-Van Creveld Syndrome/genetics , Intracellular Signaling Peptides and Proteins/genetics , Animals , Asian People/genetics , Axoneme/genetics , Child , Chlamydomonas/genetics , Cilia/genetics , Cilia/metabolism , Cytoskeleton/genetics , Cytoskeleton/metabolism , Ellis-Van Creveld Syndrome/pathology , Exome , Exons , Humans , Infant , Infant, Newborn , Mutation , Protein Conformation , Proteomics , White People/genetics
13.
Hum Mutat ; 36(1): 26-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25196272

ABSTRACT

Cornelia de Lange syndrome (CdLS) is a well-characterized developmental disorder. The genetic cause of CdLS is a mutation in one of five associated genes (NIPBL, SMC1A, SMC3, RAD21, and HDAC8) accounting for about 70% of cases. To improve our current molecular diagnostic and to analyze some of CdLS candidate genes, we developed and established a gene panel approach. Because recent data indicate a high frequency of mosaic NIPBL mutations that were not detected by conventional sequencing approaches of blood DNA, we started to collect buccal mucosa (BM) samples of our patients that were negative for mutations in the known CdLS genes. Here, we report the identification of three mosaic NIPBL mutations by our high-coverage gene panel sequencing approach that were undetected by classical Sanger sequencing analysis of BM DNA. All mutations were confirmed by the use of highly sensitive SNaPshot fragment analysis using DNA from BM, urine, and fibroblast samples. In blood samples, we could not detect the respective mutation. Finally, in fibroblast samples from all three patients, Sanger sequencing could identify all the mutations. Thus, our study highlights the need for highly sensitive technologies in molecular diagnostic of CdLS to improve genetic diagnosis and counseling of patients and their families.


Subject(s)
De Lange Syndrome/diagnosis , High-Throughput Nucleotide Sequencing/methods , Mutation , Proteins/genetics , Sequence Analysis, DNA/methods , Cell Cycle Proteins , Child , Child, Preschool , De Lange Syndrome/genetics , Female , Genetic Predisposition to Disease , Humans , Young Adult
14.
Hum Mutat ; 36(11): 1021-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26123727

ABSTRACT

Infantile-onset cerebellar atrophy (CA) is a clinically and genetically heterogeneous trait. Galloway-Mowat syndrome (GMS) is a rare autosomal recessive disease, characterized by microcephaly with brain anomalies including CA in some cases, intellectual disability, and early-infantile-onset nephrotic syndrome. Very recently, WDR73 deficiency was identified as the cause of GMS in five individuals. To evaluate the role of WDR73 mutations as a cause of GMS and other forms of syndromic CA, we performed Sanger or exome sequencing in 51 unrelated patients with CA and variable brain anomalies and in 40 unrelated patients with a diagnosis of GMS. We identified 10 patients from three CA and from two GMS families with WDR73 mutations including the original family described with CA, mental retardation, optic atrophy, and skin abnormalities (CAMOS). There were five novel mutations, of which two were truncating and three were missense mutations affecting highly conserved residues. Individuals carrying homozygous WDR73 mutations mainly presented with a pattern of neurological and neuroimaging findings as well as intellectual disability, while kidney involvement was variable. We document postnatal onset of CA, a retinopathy, basal ganglia degeneration, and short stature as novel features of WDR73-related disease, and define WDR73-related disease as a new entity of infantile neurodegeneration.


Subject(s)
Glomerulonephritis/genetics , Heredodegenerative Disorders, Nervous System/genetics , Mutation , Nephrosis/genetics , Proteins/genetics , Adolescent , Adult , Amino Acid Sequence , Biopsy , Brain/abnormalities , Brain/pathology , Child , Child, Preschool , Cohort Studies , DNA Mutational Analysis , Female , Genetic Association Studies , Glomerulonephritis/diagnosis , Heredodegenerative Disorders, Nervous System/diagnosis , Hernia, Hiatal/diagnosis , Hernia, Hiatal/genetics , Humans , Male , Microcephaly/diagnosis , Microcephaly/genetics , Molecular Sequence Data , Nephrosis/diagnosis , Neuroimaging , Pedigree , Phenotype , Proteins/chemistry , Sequence Alignment , Young Adult
15.
Hum Mol Genet ; 22(18): 3761-72, 2013 Sep 15.
Article in English | MEDLINE | ID: mdl-23704329

ABSTRACT

The sulfated polysaccharide dermatan sulfate (DS) forms proteoglycans with a number of distinct core proteins. Iduronic acid-containing domains in DS have a key role in mediating the functions of DS proteoglycans. Two tissue-specific DS epimerases, encoded by DSE and DSEL, and a GalNAc-4-O-sulfotransferase encoded by CHST14 are necessary for the formation of these domains. CHST14 mutations were previously identified for patients with the musculocontractural type of Ehlers-Danlos syndrome (MCEDS). We now identified a homozygous DSE missense mutation (c.803C>T, p.S268L) by the positional candidate approach in a male child with MCEDS, who was born to consanguineous parents. Heterologous expression of mutant full-length and soluble recombinant DSE proteins showed a loss of activity towards partially desulfated DS. Patient-derived fibroblasts also showed a significant reduction in epimerase activity. The amount of DS disaccharides was markedly decreased in the conditioned medium and the cell fraction from cultured fibroblasts of the patient when compared with a healthy control subject, whereas no apparent difference was observed in the chondroitin sulfate (CS) chains from the conditioned media. However, the total amount of CS disaccharides in the cell fraction from the patient was increased ∼1.5-fold, indicating an increased synthesis or a reduced conversion of CS chains in the cell fraction. Stable transfection of patient fibroblasts with a DSE expression vector increased the amount of secreted DS disaccharides. DSE deficiency represents a specific defect of DS biosynthesis. We demonstrate locus heterogeneity in MCEDS and provide evidence for the importance of DS in human development and extracellular matrix maintenance.


Subject(s)
Antigens, Neoplasm/genetics , Antigens, Neoplasm/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Ehlers-Danlos Syndrome/genetics , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Sulfotransferases/genetics , Cells, Cultured , Child, Preschool , Consanguinity , DNA-Binding Proteins/deficiency , Decorin/metabolism , Dermatan Sulfate/biosynthesis , Disaccharides/metabolism , Ehlers-Danlos Syndrome/metabolism , Extracellular Matrix/metabolism , Genetic Heterogeneity , Humans , Male , Mutation, Missense , Neoplasm Proteins/deficiency , Sulfotransferases/metabolism
16.
Eur J Pediatr ; 174(1): 113-8, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25446406

ABSTRACT

UNLABELLED: Infantile movement disorders are rare and genetically heterogeneous. We set out to identify the disease-causing mutation in siblings with a novel recessive neurodegenerative movement disorder. Genetic linkage analysis and whole-exome sequencing were performed in the original family. A cohort of six unrelated patients were sequenced for further mutations in the identified candidate gene. Pathogenicity of the mutation was evaluated by in silico analyses and by structural modeling. We identified the first and homozygous mutation (p.Gly114Ala) in the Mediator subunit 20 gene (MED20) in siblings presenting with infantile-onset spasticity and childhood-onset dystonia, progressive basal ganglia degeneration, and brain atrophy. Mediator refers to an evolutionarily conserved multi-subunit RNA polymerase II co-regulatory complex. Pathogenicity of the identified missense mutation is suggested by in silico analyses, by structural modeling, and by previous reporting of mutations in four distinct Mediator subunits causing neurodegenerative phenotypes. No further MED20 mutations were detected in this study. CONCLUSION: We delineate a novel infantile-onset neurodegenerative movement disorder and emphasize the Mediator complex as critical for normal neuronal function. Definitive proof of pathogenicity of the identified MED20 mutation will require confirmation in unrelated patients.


Subject(s)
Basal Ganglia Diseases/genetics , Brain/pathology , Dystonia/genetics , Mediator Complex/genetics , Muscle Spasticity/genetics , Mutation, Missense , Adolescent , Atrophy , Child, Preschool , Dystonia/diagnosis , Exome/genetics , Female , Genetic Linkage , Humans , Magnetic Resonance Imaging , Muscle Spasticity/diagnosis , Pedigree
19.
Orphanet J Rare Dis ; 19(1): 347, 2024 Sep 17.
Article in English | MEDLINE | ID: mdl-39289684

ABSTRACT

BACKGROUND: Achondroplasia is the most common form of skeletal disorder with disproportionate short stature. Vosoritide is the first disease-specific, precision pharmacotherapy to increase growth velocity in children with achondroplasia. Limb surgery is a standard approach to increase height and arm span, improve proportionality and functionality, as well as correcting deformities. The aim of this study was to gain expert opinion on the combined use of vosoritide and limb surgery in children and adolescents with achondroplasia. METHODS: An international expert panel of 17 clinicians and orthopaedic surgeons was convened, and a modified Delphi process undertaken. The panel reviewed 120 statements for wording, removed any unnecessary statements, and added any that they felt were missing. There were 26 statements identified as facts that were not included in subsequent rounds of voting. A total of 97 statements were rated on a ten-point scale where 1 was 'Completely disagree' and 10 'Completely agree'. A score of ≥ 7 was identified as agreement, and ≤ 4 as disagreement. All experts who scored a statement ≤ 4 were invited to provide comments. RESULTS: There was 100% agreement with several statements including, "Achieve a target height, arm span or upper limb length to improve daily activities" (mean level of agreement [LoA] 9.47, range 8-10), the "Involvement of a multidisciplinary team in a specialist centre to follow up the patient" (mean LoA 9.67, range 7-10), "Planning a treatment strategy based on age and pubertal stage" (mean LoA 9.60, range 8-10), and "Identification of short- and long-term goals, based on individualised treatment planning" (mean LoA 9.27, range 7-10), among others. The sequence of a combined approach and potential impact on the physes caused disagreement, largely due to a lack of available data. CONCLUSIONS: It is clear from the range of responses that this modified Delphi process is only the beginning of new considerations, now that a medical therapy for achondroplasia is available. Until data on a combined treatment approach are available, sharing expert opinion is a vital way of providing support and guidance to the clinical community.


Subject(s)
Delphi Technique , Humans , Achondroplasia/surgery , Achondroplasia/drug therapy , Child , Adolescent , Expert Testimony , Female , Male
20.
NPJ Genom Med ; 9(1): 18, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38429302

ABSTRACT

CELSR3 codes for a planar cell polarity protein. We describe twelve affected individuals from eleven independent families with bi-allelic variants in CELSR3. Affected individuals presented with an overlapping phenotypic spectrum comprising central nervous system (CNS) anomalies (7/12), combined CNS anomalies and congenital anomalies of the kidneys and urinary tract (CAKUT) (3/12) and CAKUT only (2/12). Computational simulation of the 3D protein structure suggests the position of the identified variants to be implicated in penetrance and phenotype expression. CELSR3 immunolocalization in human embryonic urinary tract and transient suppression and rescue experiments of Celsr3 in fluorescent zebrafish reporter lines further support an embryonic role of CELSR3 in CNS and urinary tract formation.

SELECTION OF CITATIONS
SEARCH DETAIL